ストックスクリーナーアプリを入手
0.9448
31.04%
-0.4252
プレマーケット:
.81
-0.1348
-14.27%
前日終値:
$1.37
開ける：
$1.3
24時間の取引高:
3.20M
Relative Volume:
0.41
時価総額：
$4.48M
収益：
$5.66M
当期純損益:
$-15.88M
株価収益率:
-0.0835
EPS:
-11.3134
ネットキャッシュフロー:
$-10.93M
1週間 パフォーマンス:
-37.43%
1か月 パフォーマンス:
-49.74%
6か月 パフォーマンス:
-31.54%
1年 パフォーマンス:
-87.99%
1日の値動き範囲:
$0.94
$1.30
1週間の範囲:
$0.94
$1.67
52週間の値動き範囲:
$0.693
$13.80
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
名前
Bioaffinity Technologies Inc
セクター
電話
210-698-5334
住所
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.9448 | 6.50M | 5.66M | -15.88M | -10.93M | -11.31 |
TMO
Thermo Fisher Scientific Inc
|
472.63 | 176.04B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
181.35 | 128.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
573.00 | 44.96B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
128.34 | 36.88B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
360.54 | 35.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
Bioaffinity Technologies Inc (BIAF) 最新ニュース
bioAffinity Technologies Warrant (BIAFW) Holds Steady at $0.16 as Trading Remains QuietRevenue Weighted - newsline.com
BIAF Q3 2025 Earnings: Wider-than-Expected Loss Misses EstimatesEarnings Miss Streak - newsline.com
BioAffinity Technologies Files to Offer 2.63M Shrs or Pre-Funded Warrants - Moomoo
BIAF News | BIOAFFINITY TECHNOLOGIES INC (NASDAQ:BIAF) - ChartMill
Bioaffinity TechnologiesOffers 2.63 Million Shares Of Common StockSEC Filing - TradingView
[S-1] bioAffinity Technologies, Inc. Files IPO Registration Statement - Stock Titan
BIAFW Holds Steady Amid Warrant Market Uncertainty: Support and Resistance in Tight RangeElliott Wave Entry - newsline.com
bioAffinity Technologies, Inc. - MLQ.ai
BIAF Stock Chart | BIOAFFINITY TECHNOLOGIES INC (NASDAQ:BIAF) - ChartMill
bioAffinity Technologies Stock Draws Fresh Attention From Traders - Bez Kabli
Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar - BioSpace
bioAffinity Showcases CyPath Lung in Upcoming Clinical Webinar - TipRanks
bioAffinity webinar to showcase CyPath Lung's role in early-stage lung cancer detection - TradingView
bioAffinity Technologies (BIAF) spotlights CyPath Lung test in SAB lung cancer webinar - Stock Titan
BIAF Q3 2025 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Continues DevelopmentManagement Guidance Update - thelegaladvocate.com
bioAffinity Technologies (BIAF) Edges Higher Amidst Support Test – Potential for BreakoutGap Down Bounce Plays - newsline.com
BIAFW Warrants Trade Flat Near Support Amidst Quiet Market ConditionsEntry Point Alerts - newsline.com
bioAffinity Technologies (BIAF) Holds Steady at $1.65 as Consolidation PersistsTechnical Analysis Picks - newsline.com
bioAffinity receives patent allowance in Mexico for lung test - Investing.com UK
bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology - BioSpace
bioAffinity receives patent allowance in Mexico for lung test By Investing.com - Investing.com Nigeria
bioAffinity Technologies notifies Mexico patent allowance for CyPath® Lung flow cytometry method - TradingView
Mexico backs bioAffinity (NASDAQ: BIAF) patent on CyPath Lung test - Stock Titan
bioAffinity Gains Mexican Patent for CyPath Lung Diagnostic - TipRanks
bioAffinity Technologies (BIAF) News Flow - Moomoo
Number of shareholders of bioAffinity Technologies, Inc. – NASDAQ:BIAF - TradingView
BIAF Q3 2025 Earnings: EPS Misses Estimates Amid No Revenue, Stock DeclinesEarnings Miss Streak - newsline.com
What's Driving bioAffinity Technologies' Recent Surge - Kavout
Top AIAI (AIAI) Competitors 2026 - MarketBeat
bioAffinity Technologies Inc (BIAF) Stock Price, Quote, News & History - Benzinga
BIAF Stock Price, Quote & Chart | BIOAFFINITY TECHNOLOGIES INC (NASDAQ:BIAF) - ChartMill
bioAffinity (BIAF) registers 497,483 resale shares, includes 365,603 warrants - Stock Titan
BIAF Stock Slips Post Q1 Earnings Despite Strength in CyPath Lung - The Globe and Mail
[EFFECT] bioAffinity Technologies, Inc. SEC Filing - Stock Titan
bioAffinity reports 300% jump in lung test sales in April - Investing.com UK
bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Ye - PharmiWeb.com
bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026 - 01net
bioAffinity Technologies Reports Record 300% Growth in CyPath® Lung Diagnostic Test Sales in April 2026 - Minichart
bioAffinity CyPath Lung Test Sales Surge Sharply - TipRanks
TradingKey - TradingKey
bioAffinity reports 300% jump in lung test sales in April By Investing.com - Investing.com Australia
bioAffinity Reports Record Monthly CyPath Lung Unit Sales, April Up Nearly 300% - TradingView
Record CyPath Lung growth at bioAffinity (NASDAQ: BIAF) with April unit sales up nearly 300% - Stock Titan
bioAffinity Technologies, Inc. 2026 Q1 10-Q Filing: Financial Results, Risk Factors, and Forward-Looking Statements - Minichart
bioAffinity Technologies reports net loss of USD 3.6M in Q1 2026 - Medical Buyer
Bioaffinity Technologies Inc (BIAF) 財務データ
収益
当期純利益
現金流量
EPS
0.56%
0.44%
大文字化:
|
ボリューム (24 時間):